Stockreport

InnovAge reaffirms $900M-$950M revenue and $56M-$65M adjusted EBITDA guidance for fiscal 2026 while highlighting leadership transitions [Seeking Alpha]

InnovAge Holding Corp.  (INNV) 
NASDAQ:AMEX Investor Relations: innovuspharma.com
PDF CEO Patrick Blair opened by emphasizing that "the first quarter reporting cycle always comes quickly due to SEC requirements," and focused on progress against strategic [Read more]